샘플 요청 목록

 카트 문의
시장보고서
상품코드
1758958

세계의 다리에병 치료제 시장

Darier Disease Drugs
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 172 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

다리에병 치료제 세계 시장은 2030년까지 2억 2,390만 달러에 달할 전망

2024년에 1억 8,260만 달러로 추정되는 다리에병 치료제 세계 시장은 2030년에는 2억 2,390만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 3.5%로 성장할 것으로 예측됩니다. 이 보고서에서 분석된 부문 중 하나인 액체 보어 커넥터는 CAGR 4.3%를 기록하며 분석 기간 종료까지 1억 4,190만 달러에 달할 것으로 예측됩니다. 가스 보어 커넥터 부문의 성장은 분석 기간 동안 CAGR 2.0%로 추정됩니다.

미국 시장은 4,980만 달러로 추정, 중국은 CAGR 6.6%로 성장 예측

미국의 다리에병 치료제 시장은 2024년에 4,980만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 4,500만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 6.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 1.3%와 2.7%로 예측됩니다. 유럽에서는 독일이 CAGR 2.0%로 성장할 것으로 예측됩니다.

세계의 다리에병 치료제 시장 - 주요 동향과 촉진요인 정리

왜 피부과 치료에서 다래끼병이 복잡한 문제인가?

다리에병(일명: 모낭성 각화증)은 신체, 특히 가슴, 등, 이마, 두피 등 지루성 부위에 사마귀 모양의 반점이 나타나는 희귀한 만성 유전성 피부질환으로, ATP2A2 유전자의 돌연변이로 인해 발생하며, 칼슘 신호전달 장애와 세포접착 장애를 일으켜 각질세포의 기능 장애와 피부의 피부의 질감 이상을 유발합니다. 생명을 위협하지는 않지만, 다리에병은 종종 고통스럽고, 낙인찍히며, 세균 감염에 취약하고, 삶의 질에 심각한 영향을 미칩니다.

다리에병은 희귀성과 만성적인 진행으로 인해 역사적으로 연구가 부족하고 치료 접근법도 대증요법으로 제한되어 있습니다. 확립된 치료법은 없으며, 치료 전략은 일반적으로 국소 코르티코스테로이드, 레티노이드, 각질 용해제를 사용하여 염증을 조절하고, 각질 제거를 촉진하며, 박테리아의 정착을 감소시키는 것을 목표로 합니다. 표적화된 질환 조절 요법이 없기 때문에 이 질환은 피부과 및 희귀질환 연구에서 미충족 수요가 높은 분야입니다.

현재 치료법과 새로운 치료법은 이 질병을 어떻게 다루고 있는가?

현재 다리에병에 대한 치료 요법은 피부과 약물의 적응증 외 사용에 크게 의존하고 있습니다. 트레티노인이나 아다팔렌과 같은 국소 레티노이드는 일반적으로 각질화를 정상화하기 위해 사용되며, 아세트레틴이나 이소트레티노인과 같은 전신 레티노이드는 중증 환자에게 처방됩니다. 이러한 치료법은 일시적인 완화를 가져오는 경우가 많지만, 피부 건조, 자극, 기형 유발 위험과 같은 장기적인 부작용으로 인해 한계가 있습니다. 부신피질 스테로이드 외용제는 염증을 억제하는 데 도움이 되지만, 장기간 사용 시 피부 위축의 위험이 있습니다.

새로운 치료 전략으로 유전자 치료, 칼슘 조절, 면역 표적 접근법의 가능성이 모색되고 있으며, ATP2A2의 기능 회복 및 칼슘 이상 교정을 목표로 하는 저분자 조절제가 전임상시험에서 평가되고 있습니다. 또한, 건선 및 아토피 피부염에 사용되는 면역억제제 및 생물학적 제제의 재사용이 최근 주목받고 있으며, 중증 또는 난치성 다리에병 환자에 대한 유효성을 검증하기 위한 초기 임상시험이 진행되고 있습니다. 피부 유전체학 및 환자 계층화의 발전은 궁극적으로 이 틈새 시장에서 개별화된 치료 프로토콜로 이어질 수 있습니다.

어떤 환자 니즈와 헬스케어 갭이 치료법 개발을 촉진하고 있는가?

피부 병변이 눈에 띄게 만성화되어 재발성 감염, 악취, 통증, 정신적 고통에 시달리는 경우가 많습니다. 재발은 더위, 땀, 자외선 노출에 의해 유발되는 경우가 많으며, 장기적인 질병 관리와 생활습관 조절이 필요합니다. 이 때문에 특히 표준화된 치료 알고리즘이나 질환별 치료법이 없는 경우 피부과 의사, 일차 진료 의사, 간병인에게 큰 부담이 될 수 있습니다.

중요한 문제는 이 희귀 질환에 초점을 맞춘 임상시험이 이루어지지 않아 의약품 승인 경로가 제한되어 있어 기존 치료법의 일화적 사용이나 적응증 외 사용에 의존하고 있다는 점입니다. 다리에병 치료제 시장은 환자 수가 적고, 지리적으로 분산되어 있으며, 비전문 임상의들의 질환에 대한 인식이 낮기 때문에 더욱 제한적입니다. 그러나 희귀 피부질환에 대한 관심이 높아지고 환자 옹호 운동이 활발해지면서 이 분야에 대한 연구 관심과 의료 지원의 틀이 조금씩 확대되고 있습니다.

다리에병 치료제 시장의 성장을 촉진하는 요인은 무엇인가?

다리에병 치료제 시장의 성장은 여러 가지 복합적인 요인에 의해 주도되고 있습니다. 희귀 피부질환이 희귀질환 치료제의 개발 대상으로 인식되면서 생명공학 기업 및 학술 연구기관의 관심을 끌고 있습니다. 유전자 검사 및 진단 도구의 가용성이 높아지면서 조기 진단과 환자 계층화가 개선되어 보다 정확하고 시기적절한 개입이 가능해졌습니다.

관련 만성 피부질환에 대한 전신요법 및 생물학적 제제의 성공은 특히 중등도에서 중증의 증상을 가진 환자들을 대상으로 한 다리에병에 대한 약물의 재사용 및 적응증 외 사용을 장려하고 있습니다. 희귀질환에 대한 보험급여의 틀과 규제적 혜택이 확대됨에 따라 소수의 환자군을 대상으로 한 표적 치료제 개발에 유리한 조건이 조성되고 있습니다. 마지막으로, 옹호 그룹과 디지털 헬스 플랫폼을 통한 환자 참여의 확대는 인지도를 높이고 공동 임상 연구를 촉진하고 있습니다. 이러한 역학관계로 인해 희귀질환 치료제의 시장 환경은 더욱 구조화되고 있으며, 점차 기회가 마련되고 있습니다.

부문

제품 유형(액체 보어 커넥터, 가스 보어 커넥터)

조사 대상 기업 사례(총 34개사)

  • AbbVie Inc.
  • Allergan plc
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • BioMarin Pharmaceutical Inc.
  • BridgeBio Pharma Inc.
  • Galderma SA
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson
  • Laminar Pharma
  • Mayne Pharma Group Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Recursion Pharmaceuticals Inc.
  • Sigmapharm Laboratories LLC.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals Inc.

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장과 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범에 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.10

Global Darier Disease Drugs Market to Reach US$223.9 Million by 2030

The global market for Darier Disease Drugs estimated at US$182.6 Million in the year 2024, is expected to reach US$223.9 Million by 2030, growing at a CAGR of 3.5% over the analysis period 2024-2030. Liquid Bore Connector, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$141.9 Million by the end of the analysis period. Growth in the Gas Bore Connector segment is estimated at 2.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$49.8 Million While China is Forecast to Grow at 6.6% CAGR

The Darier Disease Drugs market in the U.S. is estimated at US$49.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$45.0 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.3% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.0% CAGR.

Global Darier Disease Drugs Market - Key Trends & Drivers Summarized

Why Is Darier Disease a Complex Challenge in Dermatological Therapy?

Darier disease-also known as keratosis follicularis-is a rare, chronic genetic skin disorder characterized by wart-like blemishes on the body, particularly in seborrheic areas such as the chest, back, forehead, and scalp. Caused by mutations in the ATP2A2 gene, the disease results in impaired calcium signaling and disrupted cell adhesion, leading to keratinocyte dysfunction and abnormal skin texture. While not life-threatening, Darier disease is often painful, stigmatizing, and susceptible to bacterial infections, severely affecting quality of life.

Due to its rarity and chronic progression, Darier disease has been historically under-researched, and therapeutic approaches are largely limited to symptom management. There is no established cure, and treatment strategies typically involve topical corticosteroids, retinoids, and keratolytics aimed at controlling inflammation, promoting desquamation, and reducing bacterial colonization. The lack of targeted, disease-modifying therapies makes this an area of high unmet need within dermatology and rare disease research.

How Are Current Therapies and Emerging Treatments Addressing the Disease?

Current treatment regimens for Darier disease rely heavily on off-label use of dermatological agents. Topical retinoids like tretinoin and adapalene are commonly used to normalize keratinization, while systemic retinoids such as acitretin and isotretinoin are prescribed in severe cases. These therapies often provide temporary relief but are limited by long-term side effects, including skin dryness, irritation, and teratogenic risks. Topical corticosteroids help manage inflammation but pose risks of skin atrophy with extended use.

Emerging treatment strategies are exploring the potential of gene therapy, calcium modulation, and immune-targeted approaches. Small molecule modulators aimed at restoring ATP2A2 function or compensating for calcium dysregulation are under preclinical evaluation. Additionally, recent interest in repurposing immunosuppressive agents and biologics-used in psoriasis or atopic dermatitis-is driving early-phase trials to test efficacy in severe or refractory Darier disease cases. Advances in dermatogenomics and patient stratification may eventually lead to personalized therapeutic protocols in this niche segment.

Which Patient Needs and Healthcare Gaps Are Driving Therapeutic Development?

Patients with Darier disease often suffer from recurrent infections, malodor, pain, and emotional distress due to the visible and chronic nature of their skin lesions. Flare-ups are frequently triggered by heat, sweating, and UV exposure, necessitating long-term disease management and lifestyle adjustments. This places a significant burden on dermatologists, primary care physicians, and caregivers, especially in the absence of standardized treatment algorithms or disease-specific therapies.

A key challenge is the lack of clinical trials focused on this orphan condition, which results in limited drug approval pathways and reliance on anecdotal or off-label use of conventional therapies. The market for Darier disease drugs is further constrained by low patient numbers, geographic dispersion, and poor disease awareness among non-specialist clinicians. Nonetheless, increasing attention to rare dermatological disorders and patient advocacy is driving a modest expansion of research interest and healthcare support frameworks in this area.

What Factors Are Driving Growth in the Darier Disease Drugs Market?

The growth in the Darier disease drugs market is driven by several intersecting factors. Increasing recognition of rare dermatological conditions as viable targets for orphan drug development is attracting attention from biotech firms and academic research institutions. The rising availability of genetic testing and diagnostic tools is improving early diagnosis and patient stratification, thereby facilitating more accurate and timely interventions.

The success of systemic and biologic therapies in related chronic skin diseases is encouraging drug repurposing and off-label exploration in Darier disease, particularly for patients with moderate-to-severe manifestations. Expanded reimbursement frameworks and regulatory incentives for orphan diseases are creating favorable conditions for the development of targeted therapies, even in small populations. Lastly, greater patient engagement through advocacy groups and digital health platforms is elevating awareness and encouraging collaborative clinical research. Together, these dynamics are gradually shaping a more structured and opportunity-rich market environment for Darier disease therapeutics.

SCOPE OF STUDY:

The report analyzes the Darier Disease Drugs market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Liquid Bore Connector, Gas Bore Connector)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • AbbVie Inc.
  • Allergan plc
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • BioMarin Pharmaceutical Inc.
  • BridgeBio Pharma Inc.
  • Galderma SA
  • GlaxoSmithKline plc
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson
  • Laminar Pharma
  • Mayne Pharma Group Ltd.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Recursion Pharmaceuticals Inc.
  • Sigmapharm Laboratories LLC.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar Pharmaceuticals Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Darier Disease Drugs - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Awareness of Rare Dermatological Disorders Propels Demand for Darier Disease Treatments
    • Expansion of Orphan Drug Designations Strengthens the Business Case for Targeted Therapeutics
    • Rising Dermatologist Engagement and Patient Advocacy Throws the Spotlight on Underdiagnosed Conditions
    • Limited Efficacy of Existing Off-Label Treatments Spurs Innovation in Novel Drug Classes
    • Growth in Genomic Research and Pathophysiology Studies Accelerates Development of Precision Therapies
    • Increased Use of Retinoids and Systemic Therapies Drives Demand for Optimized Formulations
    • Regulatory Support for Accelerated Approval Pathways Expands Market Entry Opportunities
    • Improved Patient Registry and Disease Tracking Infrastructure Enhances Clinical Trial Feasibility
    • Demand for Non-Invasive, Topical Solutions Fuels Innovation in Dermatological Drug Delivery
    • Rising Access to Specialized Dermatology Centers Improves Diagnosis and Prescription Volumes
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Darier Disease Drugs Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Darier Disease Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Darier Disease Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Darier Disease Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Liquid Bore Connector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Liquid Bore Connector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Liquid Bore Connector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Gas Bore Connector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Gas Bore Connector by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Gas Bore Connector by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • JAPAN
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • CHINA
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • EUROPE
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Darier Disease Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Darier Disease Drugs by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Darier Disease Drugs by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • FRANCE
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • GERMANY
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Darier Disease Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Darier Disease Drugs by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Darier Disease Drugs by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • INDIA
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Darier Disease Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Darier Disease Drugs by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Darier Disease Drugs by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Darier Disease Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Darier Disease Drugs by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Darier Disease Drugs by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030
  • AFRICA
    • Darier Disease Drugs Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Darier Disease Drugs by Product Type - Liquid Bore Connector and Gas Bore Connector Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Darier Disease Drugs by Product Type - Percentage Breakdown of Value Sales for Liquid Bore Connector and Gas Bore Connector for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제